NCT05919875

Brief Summary

The goal of this clinical trial is to evaluate the effectiveness of the online 6-weeks Mindfulness-Based Cognitive Therapy (iMBCT) in depressed sample and compare the guided intervention to an unguided one. The main questions the study aims to answer are:

  • To what extent completing iMBCT will reduce the severity of depressive symptoms in mild to moderately depressed sample?
  • What are the differences in participants who completed the program or responded to treatment and those who discontinued it?
  • What are the differences in treatment effect between two active conditions (guided and unguided iMBCT) and a passive one - waiting-list group? Researchers will compare two iMBCT interventions with a waiting-list group to assess the therapeutic effects of iMBCT on depression, anxiety and other measures related to the mental health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

June 26, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

March 18, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 29, 2024

Completed
Last Updated

November 25, 2024

Status Verified

June 1, 2023

Enrollment Period

5 months

First QC Date

May 31, 2023

Last Update Submit

November 20, 2024

Conditions

Keywords

mindfulness-based cognitive therapydepressiononline intervention

Outcome Measures

Primary Outcomes (6)

  • Change in levels of depression - first tool

    The Patient Health Questionnaire (PHQ-9): It is a brief self-administered tool for screening and assessing depression severity according to the DSM criteria (Kroenke et al., 2001). Respondents rate the statements on a 4-points scale, yielding a score between 0 and 27.

    Baseline, week 6 and week 18

  • Change in levels of depression - second tool

    To increase the reliability of diagnosis, second tool measuring depression will be used: The Center for Epidemiologic Studies Depression Scale (Radloff, 1977). It is a 20-item instrument with each item rated on a four-point scale ranging from 0 ("rarely or none of the time") to 3 ("most or all of the time").

    Baseline, week 6 and week 18

  • Change in levels of anxiety

    Generalized Anxiety Disorder (GAD-7) scale: it is a brief tool that consists of seven items measuring worry and anxiety symptoms. (Spitzer et al., 2006). Each item is scored on a four-point Likert scale (0-3) with total scores ranging from 0 to 21 with higher scores reflecting greater anxiety severity.

    Baseline, week 6 and week 18

  • Change in levels of self-compassion

    Self-compassion will be measured with a short form of Self-Compassion Scale (SCS-SF; Raes et al., 2011). The tool consists of 12 items (eg. 'I try to see my failings as part of the human condition.') to which person refers on a five-point scale.

    Baseline, week 6 and week 18

  • Change in level of resilience

    The level of resilience will be computed with polish Resilience Measurement Scale (The Resiliency Assessment Scale, SPP-25; Ogińska - Bulik, Juczyński, 2008). The scale consists of 25 statements (e. g. I can easily adapt to new situations) to which respondent relates on a five-point Likert scale.

    Baseline, week 6 and week 18

  • Change in levels of mindfulness

    Five Facet Mindfulness Questionnaire-15 (FFMQ-15): It is a short tool to measure mindfulness as a trait. The items will be measured on a 5-point Likert-type scale from 1 (never or rarely true) to 5 (very often or always true). Example items include: "I do jobs or tasks automatically without being aware of what I'm doing"

    Baseline, week 6 and week 18

Secondary Outcomes (3)

  • Change in levels of rumination

    Baseline, week 6 and week 18

  • Change in levels of cognitive fusion

    Baseline, week 6 and week 18

  • Change in levels of experiential avoidance

    Baseline, week 6 and week 18

Other Outcomes (6)

  • Ecological momentary assessment

    Week 1,2 and 6

  • Working Alliance

    week 2

  • Credibility and Expectancy

    week 2

  • +3 more other outcomes

Study Arms (3)

Unguided iMBCT intervention

EXPERIMENTAL
Behavioral: Unguided Mindfulness-Based Cognitive Therapy

Guided iMBCT intervention

EXPERIMENTAL
Behavioral: Guided Mindfulness-Based Cognitive Therapy

Waiting list group

NO INTERVENTION

Interventions

The unguided iMBCT intervention is divided into six sessions. The sessions are an online adaptation of the regular MBCT. Subsequent sessions are unlocked gradually, once a week. The training consists of audio/video recordings and a workbook. Materials are recorded by a certified MBCT teacher and represent topics raised during regular courses: 1. Awareness and automatic pilot 2. Living in our heads 3. Being present in the body 4. Recognizing aversion 5. Allowing / Letting be 6. "How can I best take care of myself?" The intervention requires daily commitment of about 30-40 minutes.

Unguided iMBCT intervention

The guided iMBCT intervention consists of six online meetings in groups of maximum 25 participants. The weekly meetings will be led by an experienced and certified MBCT teacher. The course of the meeting will represent thematically the unguided condition according to the agenda: * Introduction to the topic * Guided meditation * Brief inquiry and discussion * Setting tasks for the upcoming week To reduce the number of differences between the conditions as much as possible and narrow it down to the active participation of the teacher, the meetings will be modified version of MBCT and will last maximum 90 minutes. Between the meetings participants will be ask to practice daily 30-40 minutes mindfulness exercises.

Guided iMBCT intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • meeting the screening criterions for depression
  • confirmed diagnosis in the clinical interview - mild to moderate depressive episode
  • years old or older
  • informed consent
  • fluent in Polish
  • willing to be randomized to intervention or waiting list group

You may not qualify if:

  • lack of depressive symptoms constituting mild or moderate episode of depression
  • suicidality
  • severe depression
  • current substance use disorder, psychotic disorders, bipolar
  • current psychotherapy
  • if antidepressant medication: has not been stable over the last 4 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Warsaw

Warsaw, Poland

Location

Related Publications (5)

  • Surewicz WK. Effect of osmotic gradient on the physical properties of membrane lipids in liposomes. Chem Phys Lipids. 1983 Jul;33(1):81-5. doi: 10.1016/0009-3084(83)90010-5.

    PMID: 6313244BACKGROUND
  • Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000 Aug;68(4):615-23. doi: 10.1037//0022-006x.68.4.615.

    PMID: 10965637BACKGROUND
  • Goldberg SB, Tucker RP, Greene PA, Davidson RJ, Wampold BE, Kearney DJ, Simpson TL. Mindfulness-based interventions for psychiatric disorders: A systematic review and meta-analysis. Clin Psychol Rev. 2018 Feb;59:52-60. doi: 10.1016/j.cpr.2017.10.011. Epub 2017 Nov 8.

    PMID: 29126747BACKGROUND
  • Segal ZV, Dimidjian S, Beck A, Boggs JM, Vanderkruik R, Metcalf CA, Gallop R, Felder JN, Levy J. Outcomes of Online Mindfulness-Based Cognitive Therapy for Patients With Residual Depressive Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2020 Jun 1;77(6):563-573. doi: 10.1001/jamapsychiatry.2019.4693.

    PMID: 31995132BACKGROUND
  • Chariyalertsak S, Sugano K, Ohkura H, Mori Y. Comparison of c-erbB-2 oncoprotein expression in tissue and serum of patients with stomach cancer. Tumour Biol. 1994;15(5):294-303. doi: 10.1159/000217904.

    PMID: 7991990BACKGROUND

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Jan Wardęszkiewicz, MSc

    University of Warsaw

    PRINCIPAL INVESTIGATOR
  • Paweł Holas, Ph.D.

    University of Warsaw

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Msc

Study Record Dates

First Submitted

May 31, 2023

First Posted

June 26, 2023

Study Start

March 18, 2024

Primary Completion

July 31, 2024

Study Completion

October 29, 2024

Last Updated

November 25, 2024

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

We will provide data upon reasonable request.

Locations